Treace Medical Concepts Inc expected to post a loss of 30 cents a share - Earnings Preview

Treace Medical Concepts

06/05/2025 21:29

Treace Medical Concepts Inc TMCI.OQ TMCI.O is expected to show a rise in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Ponte Vedra Florida-based  company is expected to report a 1.9% increase in revenue to $52.07 million from $51.11 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Treace Medical Concepts Inc is for a loss of 30 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Treace Medical Concepts Inc is $10.00​, above​ its last closing price of $7.32. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.04
-0.04
-0.01
Beat
74.1
Sep. 30 2024
-0.27
-0.27
-0.25
Beat
8
Jun. 30 2024
-0.29
-0.29
-0.29
Met
0​
Mar. 31 2024
-0.30
-0.30
-0.30
Met
0.9
​​Dec. 31 2023
-0.09
-0.09
-0.10
Missed
-12.9
Sep. 30 2023
-0.25
-0.26
-0.28
Missed
-7.1​
Jun. 30 2023
-0.23
-0.24
-0.20
Beat
16.1
Mar. 31 2023
-0.23
-0.23
-0.23
Met
-0.7

This summary was machine generated May 6 at 20:29 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)